Group 1 - The core point of the article is that Huajian Medical (01931.HK) has officially completed the construction of the ETHK Building in Nanjing, China, which focuses on the research and development of digital technology for Real World Assets (RWA) [1] - This development marks a significant breakthrough in the company's "ETHK blockchain financial ecosystem strategy," emphasizing its commitment to foundational technology research and the construction of digital financial infrastructure [1] - The completion of the ETHK Building demonstrates the company's extraordinary determination and execution capability in transitioning from conceptual leadership to large-scale practical RWA technology development [1] Group 2 - As of September 19, 2025, Huajian Medical's stock closed at HKD 10.62, down 3.45%, with a trading volume of 533,000 shares and a turnover of HKD 5.7233 million [1] - The company has a market capitalization of HKD 17.804 billion, ranking second in the pharmaceutical commercial II industry [1] - Key financial metrics for Huajian Medical include a Return on Equity (ROE) of 4.69%, revenue of HKD 3.079 billion, and a net profit margin of 3.02%, with its debt ratio at 42.78% [1]
华检医疗(01931.HK)：全球首个RWA大厦-ETHK大厦正式落成 ETHK链上金融生态战略迈入实体化、规模化技术落地新纪元